What is being done to address the new drug epidemic?
As osteopathic physicians care for patients with complaints of pain, they commonly prescribe controlled substances. The use of these agents presents special challenges for providers, patients, and communities. The US Drug Enforcement Administration (DEA) has provided testimony to the US Congress in regard to the growing problem of diversion and misuse of such medications. Joseph T. Rannazzisi, the deputy assistant administrator in the Office of Diversion Control, appeared before the House Government Reform Committee's Subcommittee on Criminal Justice, Drug Policy, and Human Resources on July 26, 2006.
Dekker
Anthony H
AH
Phoenix Indian Medical Center, Indian Health Service, USPHS, 4212 N 16th Street, Phoenix, AZ 85016-5319, USA. Anthony.Dekker@ihs.gov
D000701:Analgesics, Opioid / Q000009:adverse effects* / Q000627:therapeutic use; D011307:Drug Prescriptions / Q000592:standards*; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence / Q000639:trends*; D006801:Humans; D009293:Opioid-Related Disorders / Q000453:epidemiology / Q000517:prevention & control*; D010148:Intractable Pain / Q000188:drug therapy*; D014481:United States / Q000453:epidemiology
D000701:Analgesics, Opioid